Assessment of Caregivers' Burden of Children with Haemophilia A on Emicizumab Prophylaxis: Single Centre Study

被引：0
|
作者：
Hassan, Eman [1 ]
Motwani, Jayashree [1 ]
机构：
[1] Birmingham Childrens Hosp, Paediat Haematol, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH22-OR40
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] The Nupower Study: Nuwiq for Perioperative Management of Patients with Haemophilia a on Emicizumab Regular Prophylaxis
    Werner, Sylvia
    Knaub, Sigurd
    [J]. BLOOD, 2022, 140 : 5625 - 5626
  • [22] Prophylaxis with emicizumab in 50 children and adolescents with severe haemophilia A without inhibitor in Uruguay: National experience
    Lemos, Felipe
    Petraccia, Carlos
    Laura Fraga, Maria
    Gomez, Rosario
    Lutz, Stefani
    Laura Casuriaga, Ana
    Inguanzo, Marianella
    Gonzalez, Jimena
    Echeverria, Silvina
    Gomez, Florencia
    Arocena, Maria
    Gonzalez, Yenirellys
    Giachetto, Gustavo
    Boggia, Beatriz
    [J]. HAEMOPHILIA, 2024, 30 : 96 - 97
  • [23] SURGERIES AND PROCEDURES IN PEOPLE WITH HAEMOPHILIA A ON EMICIZUMAB PROPHYLAXIS: ANALYSIS FROM THE ATHN 7 HAEMOPHILIA NATURAL HISTORY STUDY
    Buckner, T. W.
    Carpenter, S. L.
    Daoud, N.
    Lattimore, S. U.
    Lee, L.
    McLean, T.
    Morton, P.
    Recht, M.
    [J]. HAEMOPHILIA, 2023, 29 : 115 - 116
  • [24] UPTAKE OF EMICIZUMAB FOR PROPHYLAXIS IN CHILDREN WITH SEVERE HAEMOPHILIA A < 12 YEARS OF AGE IN THE UK.
    Mathias, M.
    Alamelu, J.
    Bhatnagar, N.
    Biss, T.
    Grainger, J.
    Green, S.
    Kelly, A.
    Motwani, J.
    Stokley, S.
    Chalmers, E.
    Payne, J.
    Payne, J.
    Payne, J.
    Payne, J.
    [J]. HAEMOPHILIA, 2021, 27 : 134 - 135
  • [25] Emicizumab prophylaxis in paediatric persons with haemophilia A (PWHA) with inhibitors: Impact on health-related outcomes and caregiver burden in the HAVEN 2 study
    Mancuso, M. E.
    Mahlangu, J.
    Sidonio, R. F., Jr.
    Trask, P. C.
    von Mackensen, S.
    Shima, M.
    Uguen, M.
    Chang, T.
    Young, G.
    Oldenburg, J.
    [J]. HAEMOPHILIA, 2018, 24 : 28 - 29
  • [26] Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study
    Janbain, Maissa
    Enjolras, Nathalie
    Bolbos, Radu
    Brevet, Marie
    Bordet, Jean-Claude
    Dargaud, Yesim
    [J]. HAEMOPHILIA, 2021, 27 (06) : 1002 - 1006
  • [27] Burden of bleeds and other determinants on caregivers of children with moderate or severe haemophilia - Results of the BBC Study
    von Mackensen, Sylvia
    Myrin-Westesson, Linda
    Escuriola, Carmen
    Kavakli, Kaan
    Klukowska, Anna
    Holland, Michael
    Khair, Kate
    [J]. HAEMOPHILIA, 2018, 24 : 148 - 148
  • [28] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    [J]. HAEMOPHILIA, 2021, 27 : 116 - 116
  • [29] Quality of life of children, adolescents with haemophilia A and its caregivers, facing change of treatment with emicizumab: Experience in Uruguay
    Lemos, Felipe
    Gonzalez, Yenirellys
    Boggia, Beatriz
    Casuriaga, Ana Laura
    Giachetto, Gustavo
    [J]. HAEMOPHILIA, 2024, 30 : 174 - 175
  • [30] Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature
    Swan, Dawn
    Paran, Sri
    Nolan, Beatrice
    [J]. HAEMOPHILIA, 2022, 28 (01) : 42 - 45
12345